| Literature DB >> 30450456 |
LaTonya J Hickson1,2,3, Wigdan H Farah2,4, Rebecca L Johnson2,5, Bjorg Thorsteinsdottir2,6, Daniel S Ubl2,7, Brandon J Yuan8, Robert Albright1, Andrew D Rule1, Elizabeth B Habermann2,7.
Abstract
INTRODUCTION: It is unknown whether patients receiving dialysis have a higher morbidity and mortality risk after hip fracture repair conferred by their kidney failure or by the high comorbidity burden often present.Entities:
Keywords: chronic kidney disease; diabetes mellitus; hip arthroplasty; hospitalization; mortality; readmission
Year: 2018 PMID: 30450456 PMCID: PMC6224855 DOI: 10.1016/j.ekir.2018.07.001
Source DB: PubMed Journal: Kidney Int Rep ISSN: 2468-0249
Figure 1Study flow diagram of inclusion, exclusion, and cohort-matching. ACS NSQIP, American College of Surgeons National Surgical Quality Improvement Program; CNS, central nervous system.
Figure 2Matching criteria for cases and controls.
Baseline characteristics and laboratory tests in dialysis-dependent patients and matched nondialysis patients undergoing hip fracture repair (American College of Surgeons National Surgical Quality Improvement Program [NSQIP] 2010−2013)
| Baseline characteristics and laboratory tests | Dialysis (n = 377) | Nondialysis (n = 1508) | Total (n = 1885) | |
|---|---|---|---|---|
| Age, yr, median (IQR) | 77 (67–84) | 78 (68–85) | 78 (68–85) | 0.068 |
| Male sex | 210 (55.7) | 840 (55.7) | 1050 (55.7) | 1.00 |
| Race | 1.00 | |||
| White | 264 (70.0) | 1056 (70.0) | 1320 (70.0) | |
| Black or African American | 24 (6.4) | 96 (6.4) | 120 (6.4) | |
| Other | 89 (23.6) | 356 (23.6) | 445 (23.6) | |
| Diabetes | 162 (43.0) | 648 (43.0) | 810 (43.0) | 1.00 |
| ASA class | <0.001 | |||
| 1 (No Disturbance) | 1 (0.3) | 19 (1.3) | 20 (1.1) | |
| 2 (Mild Disturbance) | 5 (1.3) | 246 (16.3) | 251 (13.3) | |
| 3 (Severe Disturbance) | 158 (41.9) | 959 (63.7) | 1117 (59.4) | |
| 4 (Life Threatening) | 209 (55.4) | 279 (18.5) | 488 (25.9) | |
| 5 (Moribund) | 4 (1.1) | 2 (0.1) | 6 (0.3) | |
| History of severe COPD | 63 (16.7) | 201 (13.3) | 264 (14.0) | 0.091 |
| CHF in the 30 days before surgery | 31 (8.2) | 56 (3.7) | 87 (4.6) | <0.001 |
| Current smoker within 1 yr | 46 (12.2) | 248 (16.4) | 294 (15.6) | 0.042 |
| >10% loss body weight in past 6 months | 6 (1.6) | 18 (1.2) | 24 (1.3) | 0.54 |
| Totally or Partially Dependent Functional Status | 97 (26.1) | 367 (24.6) | 464 (24.9) | 0.55 |
| Systemic sepsis | 6 (1.6) | 12 (0.8) | 18 (1.0) | 0.26 |
| Body mass index, kg/m2, median (IQR) | 24.74 (21.8–29.0) | 25.2 (21.9–29.2) | 25.1 (21.9–29.1) | 0.79 |
| ≥30 | 67 (20.3) | 283 (21.7) | 350 (21.4) | 0.59 |
| n (%) missing | 47 (12.5) | 202 (13.4) | 249 (13.2) | |
| Preoperative laboratory tests | ||||
| Serum creatinine, mg/dl, median (IQR) | 4.8991 (3.77–6.2) | 0.93 (0.72–1.25) | 1.052 (0.8–1.9) | <0.001 |
| BUN, median (IQR) | 38 (26–53.11065) | 19.6078 (14–27) | 22 (15–31.9328) | <0.001 |
| ≥33 | 228 (60.6) | 211 (14.2) | 439 (23.6) | <0.001 |
| White blood cell count, median (IQR) | 8.9 (7.1–11.35) | 9.3 (7.5–11.8) | 9.2 (7.4–11.7) | 0.11 |
| ≥10 K/mm3 | 140 (37.2) | 643 (43.1) | 783 (41.9) | 0.039 |
| Hematocrit, median (IQR) | 32.4 (29.4–36) | 35.5 (31.9–38.9) | 35 (31.1–38.3) | <0.001 |
| <30 | 104 (28.1) | 231 (15.7) | 335 (18.2) | <0.001 |
| Platelet count, median (IQR) | 177 (133–240) | 192 (153–239) | 189 (149–239) | 0.021 |
| <250 K/mm3 | 297 (79.2) | 1169 (78.7) | 1466 (78.8) | 0.82 |
| Serum albumin, g/dl, median | 3.3 (2.9–3.7) | 3.5 (3.1–3.9) | 3.5 (3.1–3.8) | <0.001 |
| <3/5 g/dl | 169 (60.1) | 392 (44.2) | 561 (48.0) | <0.001 |
| n (%) missing | 96 (25.5) | 621 (41.2) | 717 (38.0) | |
| Alkaline phosphatase, median (IQR) | 102 (78–134) | 79 (65–102) | 84 (67–110) | <0.001 |
| n (%) missing | 118 (31.3) | 693 (46.0) | 811 (43.0) | |
| SGOT, median (IQR) | 21 (16–28) | 23 (18–30) | 23 (18–30) | <0.001 |
| n (%) missing | 135 (35.8) | 697 (46.2) | 832 (44.1) | |
| Total bilirubin, median (IQR) | 0.6 (0.4–0.8) | 0.6 (0.4–0.8) | 0.6 (0.4–0.8) | 0.18 |
| n (%) missing | 143 (37.9) | 701 (46.5) | 844 (44.8) |
ASA, American Society of Anesthesiologists; BUN, blood urea nitrogen; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; SGOT, serum glutamic oxaloacetic transaminase (also known as aspartate aminotransferase [AST]).
Values are n (%) unless otherwise specified. Patients were matched on sex, age (±5 yr), race, diabetes mellitus, year of operation (±1 yr), primary procedure type (fracture fixation/arthroplasty), and anesthesia technique (general/nongeneral technique).
Data missing for the following (% of total): ASA class (0.2%), serum creatinine (2.2%), BUN (1.3%), white blood cell count (1.0%), hematocrit (2.3%), platelet count (1.3%), serum albumin (38.0%), alkaline phosphatase (43%), SGOT (44.1%), and total bilirubin (44.8%).
Hip fracture repair, hospital stay, and postoperative complications in dialysis-dependent patients and matched nondialysis patients undergoing hip fracture repair (American College of Surgeons National Surgical Quality Improvement Program [NSQIP] 2010−2013)
| Surgical procedure and complications | Dialysis (n = 377) | Nondialysis (n = 1508) | Total (n = 1885) | |
|---|---|---|---|---|
| Primary CPT procedure | 1.00 | |||
| Arthroplasty (CPT codes 27125, 27130, 27236) | 201 (53.3) | 804 (53.3) | 1005 (53.3) | |
| Fracture fixation (CPT codes 27235, 27244, 27245) | 176 (46.7) | 704 (46.7) | 880 (46.7) | |
| General anesthesia | 301 (79.8) | 1204 (79.8) | 1505 (79.8) | 1.00 |
| Principal anesthesia technique (collapsed) | 0.84 | |||
| Epidural/spinal | 70 (18.6) | 276 (18.3) | 346 (18.4) | |
| General | 301 (79.8) | 1204 (79.8) | 1505 (79.8) | |
| Nerve block (local or regional) | 1 (0.3) | 11 (0.7) | 12 (0.6) | |
| Monitored anesthesia care/i.v. sedation | 5 (1.3) | 16 (1.1) | 21 (1.1) | |
| None | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Other | 0 (0.0) | 1 (0.1) | 1 (0.1) | |
| Year of operation | 0.41 | |||
| 2010 | 33 (8.8) | 119 (7.9) | 152 (8.1) | |
| 2011 | 80 (21.2) | 290 (19.2) | 370 (19.6) | |
| 2012 | 112 (29.7) | 515 (34.2) | 627 (33.3) | |
| 2013 | 152 (40.3) | 584 (38.7) | 736 (39.0) | |
| Hospital stay: | ||||
| Days from hospital admission to operation | 0.003 | |||
| Mean (SD) | 1.57 (1.78) | 1.32 (1.37) | 1.37 (1.46) | |
| Median (IQR) | 1 (1–2) | 1 (1–2) | 1 (1–2) | |
| Range | 0 to 14 | 0 to 13 | 0 to 14 | |
| Time from admission to operation >2 days | 53 (14.1) | 165 (10.9) | 218 (11.6) | 0.091 |
| Days from operation to discharge | <0.001 | |||
| n (%) missing | 4 (1.1) | 2 (0.1) | 6 (0.3) | |
| Mean (SD) | 8.14 (8.64) | 6.13 (6.97) | 6.53 (7.37) | |
| Median (IQR) | 5 (4–9) | 4 (3–6) | 4 (3–7) | |
| Range | 0 to 64 | 0 to 76 | 0 to 76 | |
| Length of total hospital stay | <0.001 | |||
| Mean (SD) | 9.71 (9.15) | 7.45 (7.28) | 7.90 (7.73) | |
| Median (IQR) | 7 (5–11) | 5 (4–8) | 6 (4–9) | |
| Range | 1 to 75 | 0 to 77 | 0 to 77 | |
| Days from operation to discharge >7 | 119 (31.9) | 308 (20.5) | 427 (22.7) | <0.001 |
| Days from operation to discharge >14 | 45 (11.9) | 96 (6.4) | 141 (7.5) | <0.001 |
| Days from operation to discharge >20 | 28 (7.4) | 54 (3.6) | 82 (4.4) | 0.001 |
| Postoperative complications | ||||
| In-hospital death | 29 (7.7) | 27 (1.8) | 56 (3.0) | <0.001 |
| Superficial SSI | 3 (0.8) | 18 (1.2) | 21 (1.1) | 0.78 |
| Deep incisional SSI | 1 (0.3) | 8 (0.5) | 9 (0.5) | 0.70 |
| Organ space SSI | 3 (0.8) | 2 (0.1) | 5 (0.3) | 0.058 |
| Wound disruption | 1 (0.3) | 1 (0.1) | 2 (0.1) | 0.36 |
| Pneumonia | 14 (3.7) | 58 (3.8) | 72 (3.8) | 0.90 |
| Unplanned intubation | 13 (3.4) | 29 (1.9) | 42 (2.2) | 0.073 |
| Pulmonary embolism | 2 (0.5) | 13 (0.9) | 15 (0.8) | 0.75 |
| Ventilator >48 h | 6 (1.6) | 13 (0.9) | 19 (1.0) | 0.20 |
| Urinary tract infection | 10 (2.7) | 84 (5.6) | 94 (5.0) | 0.020 |
| Cardiac arrest requiring CPR | 17 (4.5) | 11 (0.7) | 28 (1.5) | <0.001 |
| Myocardial infarction | 11 (2.9) | 28 (1.9) | 39 (2.1) | 0.20 |
| DVT/thrombophlebitis | 1 (0.3) | 13 (0.9) | 14 (0.7) | 0.33 |
| Sepsis | 12 (3.2) | 26 (1.7) | 38 (2.0) | 0.071 |
| Septic shock | 8 (2.1) | 7 (0.5) | 15 (0.8) | 0.001 |
| Sepsis or septic shock | 20 (5.3) | 33 (2.2) | 53 (2.8) | 0.001 |
| Peripheral nerve injury | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Graft/prosthesis/flap failure | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Readmission within 30 days of index procedure (2011–2013) | 48 (14.0) | 125 (9.0) | 173 (10.0) | 0.006 |
CPR, cardiopulmonary resuscitation; CPT, Current Procedural Terminology; DVT, deep venous thrombosis; IQR, interquartile range; SSI, surgical site infection.
Values are n (%) unless otherwise specified. Patients were matched on sex, age (±5 yr), race, diabetes mellitus, year of operation (±1 yr), primary procedure type (fracture fixation/arthroplasty), and anesthesia technique (general/nongeneral technique).
Data missing for the following (% of total): length of stay 0.3%.
Figure 3Kaplan−Meier survival curves showing 30-day survival by dialysis status in matched patients undergoing hip fracture repair (American College of Surgeons National Surgical Quality Improvement Program [NSQIP] 2010−2013). Shading represents 95% confidence intervals (CI). HR, hazard ratio; preop, preoperative.